CLDN2 and COVID-19: When the cells were treated with MVs derived from R patients vaccinated with the COVID-19 vaccine, the response of the cells was changed, and a significant reduction in the expression of OCLN, CLDN2, and E-CAD (p < 0.005) was induced, while the other proteins were not significantly modulated.